DEPARTMENT OF CORRECTIONS: AHA
DEPARTMENT OF CORRECTIONS: AHA not AMA: Large typo in headline of item in the Aug. 15 issue of "The Pink Sheet" (T&G-1) incorrectly linked AMA with a Genentech public service announcement in the June 27 issue of Time magazine instead of the American Heart Association (AHA). The PSA was questioned by FDA as close to crossing the announcement/advertising boundary.
You may also be interested in...
Data presented at AAAI meeting show reduced annualized asthma exacerbation rates across all patient populations, but doctors are unlikely to switch patients served well by existing biologics.
The RNA drug’s accelerated approval brings Sarepta’s exon-skipping market share to nearly 30%.
Limiting interactions to two-dimensional settings will hinder collaboration, innovation and the mentoring of younger employees, Merck & Co. CEO Kenneth Frazier says. Frazier, who will retire in June, is looking forward to returning to public service but says "politics with a capital P is not my thing."